Role of carcinoma-associated fibroblasts and hypoxia in tumor progression
- PMID: 20517716
- DOI: 10.1007/82_2010_73
Role of carcinoma-associated fibroblasts and hypoxia in tumor progression
Abstract
In recent years, a variety of experimental evidence has convincingly shown that progression of malignant tumors does not depend exclusively on cell-autonomous properties of the cancer cells, but can also be influenced by the tumor stroma. The concept that cancer cells are subjected to microenvironmental control has thus emerged as an important chapter in cancer biology. Recent findings have suggested an important role, in particular, for macrophages, endothelial cells, and cancer-associated fibroblasts (CAFs) in tumor growth and progression. Numerous lines of evidence indicate that the bone marrow is the source, at least in part, of these cells. This chapter summarizes our current knowledge of how bone marrow contributes to the tumor stroma, with particular emphasis on CAFs. The potential role of hypoxia in modulating the differentiation and activity of CAFs, and the therapeutical implications of targeting CAFs for anticancer therapy are discussed.
Similar articles
-
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.Cancer Metastasis Rev. 2012 Jun;31(1-2):195-208. doi: 10.1007/s10555-011-9340-x. Cancer Metastasis Rev. 2012. PMID: 22101652 Review.
-
Cancer associated fibroblasts: the dark side of the coin.Am J Cancer Res. 2011;1(4):482-97. Epub 2011 Mar 12. Am J Cancer Res. 2011. PMID: 21984967 Free PMC article.
-
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.J Thorac Oncol. 2011 Jan;6(1):209-17. doi: 10.1097/JTO.0b013e3181f8a1bd. J Thorac Oncol. 2011. PMID: 21107292 Review.
-
GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.Biochem Biophys Res Commun. 2013 Nov 1;440(4):558-63. doi: 10.1016/j.bbrc.2013.09.108. Epub 2013 Oct 7. Biochem Biophys Res Commun. 2013. PMID: 24113381
-
Activation of fibroblasts in cancer stroma.Exp Cell Res. 2010 Oct 15;316(17):2713-22. doi: 10.1016/j.yexcr.2010.04.032. Epub 2010 May 6. Exp Cell Res. 2010. PMID: 20451516 Review.
Cited by
-
Conducive target range of breast cancer: Hypoxic tumor microenvironment.Front Oncol. 2022 Sep 26;12:978276. doi: 10.3389/fonc.2022.978276. eCollection 2022. Front Oncol. 2022. PMID: 36226050 Free PMC article. Review.
-
Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions.Explor Target Antitumor Ther. 2022;3(5):598-629. doi: 10.37349/etat.2022.00103. Epub 2022 Oct 27. Explor Target Antitumor Ther. 2022. PMID: 36338519 Free PMC article. Review.
-
Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts.Cancers (Basel). 2019 Feb 23;11(2):263. doi: 10.3390/cancers11020263. Cancers (Basel). 2019. PMID: 30813438 Free PMC article.
-
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.Cancers (Basel). 2022 Mar 16;14(6):1519. doi: 10.3390/cancers14061519. Cancers (Basel). 2022. PMID: 35326670 Free PMC article. Review.
-
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer.J Control Release. 2020 Jul 10;323:431-441. doi: 10.1016/j.jconrel.2020.04.040. Epub 2020 Apr 30. J Control Release. 2020. PMID: 32360890 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources